 General Motors Attempts to Settle For Less in LI Girl's Case.
May 26, 2009 | New York Post
They ain't too proud to beg for billions, but when it comes to compensating two Long Island girls critically injured in a horrific head-on crash, General Motors officials are telling the kids' family to settle for "pennies" -- or get nothing at all when the auto giant goes belly up, court papers show.
The girls -- one of whom is now a quadriplegic -- likely face a lifetime of medical bills.
GM's lawyers "threatened" the girls' lawyers, saying they should accept a "considerably significant reduction" in any potential settlement "lest their claims be wiped out in a bankruptcy reorganization," according to papers filed in Suffolk County Supreme Court by Stanley Sanders, lawyer for one of the children... Read Full Article Here.
Hydroxycut recalled from the market. FDA warns consumers on liver damage risks.
May 1, 2009 | FDA
The Food and Drug Administration (FDA) announced a warning to all Hydroxycut consumers to immediately stop the use of the dietary supplement produced by Iovate Health Science Inc., of Oakville, Ontario. According to the FDA number of Hydroxycut products are associated with several serious liver injuries. The drug manufacturer has agreed to recall the product from the market.
In the report the FDA stated that it has received over 23 reports of serious health problems ranging from jaundice and elevated liver enzymes, which is an indicator of potential liver injury that can lead to liver damage requiring liver transplants.
... Read Full Article Here.
Esophageal Cancer in Patients Taking Oral Bisphosphonates
February 6, 2009 | Medscape
December 31, 2008 (updated January 12, 2009, with FDA comments) — Cases of esophageal cancer in patients who had been taking oral bisphosphonate drugs for osteoporosis have been reported by an official from the Food and Drug Administration (FDA) in the January 1 issue of the New England Journal of Medicine.
"We are not able to determine if oral bisphosphonates cause or contribute to esophageal cancer without a study that collects information on known risk factors for esophageal cancer while also taking into account the oral bisphosphonate use," the author, Diane Wysowski, PhD, epidemiologist in the Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, FDA, commented to Medscape Oncology. She suggested that additional studies of this issue should be carried out.
... Read Full Article Here.
FDA report finds multiple problems at peanut plant
January 28 , 2009 | Associated Press, Ricardo Alonso-Zaldivar & Greg Bluestein | Filed Under: Peanut Butter, Peanut Products, Salmonella Contaminated Peanuts
Roaches, mold, and signs of a leaking roof were among numerous problems federal inspectors uncovered at a Georgia peanut plant implicated in the national salmonella outbreak, the government said Wednesday.
Food and Drug Administration inspectors noted ten separate problem areas in the report, which the agency posted on the Internet... Read Full Article Here.
Hospital infections spread, so do lawsuits
December 1 , 2008 | Wisconsin Law Journal, Sylvia Hsieh | Filed Under: Hospital infections
Boston — A new type of med-mal lawsuit is on the increase — claims based on hospital infections.
Several recent verdicts and settlements illustrate this trend:
On Nov. 6, a jury awarded $13.5 million to a Massachusetts woman who died of an infection... Read Full Article Here.
Doctors Claim Glaxo Dismissed Worried on Avandia -- Drug Maker Tried to Make Physician at Maryland Hospital Stop Talking About concerns; Company Defends Its Effort
November 19 , 2008 | The Wall Street Journal
Filed Under: Defective Drugs, Avandia
A ruckus erupted last year when reports surfaced that Glaxo was accused of intimidating John Buse, a University of North Carolina researcher who, years earlier, questioned the safety of its Avandia diabetes pill, which was linked to heart problems. However, he wasn’t the only one the drugmaker tried to stifle.
A doctor from a small Maryland hospital linked Avandia to congestive heart failure in 2000... Read Full Article Here.
Public Citizen Petitions FDA to Ban Diabetes Drug Avandia, According to Avandia Plaintiffs Attorney Group
November 6 , 2008 | LexisNexis Press Release
Filed Under: Defective Drugs, Avandia
National non-profit organization documents upsurge in negative clinical data associated with use of Avandia, urges FDA commissioner to remove drug from U.S. market immediately Thus, it is urgent for the FDA to immediately ban rosiglitazone (Avandia). Read Full Article Here.
Reports of serious drug reactions hit record
October 23 , 2008 | Associated Press
Filed Under: Defective Drugs, Chantix, Heparin
The number of serious drug reactions and deaths reported to the government shot up in the first three months of this year to set a new record, a health industry watchdog group said Wednesday.
The Food and Drug Administration received nearly 21,000 reports of serious drug reactions, including more than 4,800 deaths, said an analysis of federal data by the Institute for Safe Medication Practices.
Two drugs accounted for a large share of the latest reports. One was the blood thinner heparin. Most of the drug's problems were prompted by tainted heparin imported from China. The other was Chantix, a new kind of anti-smoking drug from Pfizer ... Read More.
Sanders Law Firm Files Claim for Good Samaritan Beaten by NYC Cops Gone Wild
August 22 , 2008 | Press Release
Filed Under: Police Brutality
Marc Grossman, Senior Partner of the law firm of Sanders, Sanders, Block, Woycik, Viener & Grossman, P.C. in Bronx, New York, announced today that it has just filed a Notice of Claim against The City of New York and The New York City Police Department.. Read More.
Acid reflux drugs may be linked to increased risk of osteoporosis-related fractures.
August 11 , 2008 | WebMD
Filed Under: Acid Reflux Drugs
Using acid reflux drugs called proton pump inhibitors for at least seven years may be linked to increased risk of osteoporosis-related fractures Read More.
Chantix Out at One U.S. Military Base
August 11 , 2008 | NewsInferno
Filed Under: Chantix Lawsuit, Chantix Lawyer, Chantix News
Not letting people who are carrying rifles to take a drug that has been linked to suicide sounds like a good idea to me. Marc Grossman. Read More.
New-York Based Sanders Law Firm Files Five Product Liability Lawsuits Against Pfizer on Behalf of Chantix Plaintiffs.
August 5 , 2008 | Lexis Nexis Press Release
Filed Under: Chantix Lawsuit, Chantix Lawyer, Chantix News
Leading personal injury law firm representing families of individuals who suffered from suicidal thoughts and erratic behavior while taking popular smoking cessation drug. Read More.
$ 8 Million in 8 Days
May 29, 2008 | Partner Marc Grossman
Filed Under: Personal Injury, Vioxx Litigation Press Release
In the past eight days, our law firm has recovered over $8 Million for our clients. Our most recent recovery was a $5.0 MILLION DOLLAR SETTLEMENT. In a product liability action litigated in Federal Court, Eastern District, David Woycik, Jr. obtained a 5.0 Million Dollar settlement award for a paraplegic injured as a result of an accident occasioned by a defective bicycle.
Plaintiff, 52 years of age and a tri-athlete, was riding his bicycle on June 10, 2006 in Heckscher State Park in Suffolk County. While approximately one-quarter of the way around the first of three loops, plaintiff’s bicycle stopped suddenly causing him to be catapulted over the handlebar and to land on the ground on his head.
As a result of the accident, plaintiff severed his spinal cord, leaving him a paraplegic.
In a vigorously contested case, through relentless discovery, exhaustive and diligent post-accident investigation and employment of reputable engineering, reconstructive and material science experts, Mr. Woycik was able to establish that fractures and cracks in the reinforced aranid carbon fiber front fork of plaintiff’s bicycle- manufactured, designed and sold by defendants- was responsible for the sudden stopping of the bicycle and the ensuing accident.
Another $2.4Million recovery was obtained last week in a Construction Accident Case by Partner Stanley J. Sanders and an $850,000 settlement was reached by Partners Martin Block and Meryl Sanders Viener in a lead point poisoning case.
Our Firm continues to achieve excellent results for our clients each and every week of the year. We at The Sanders Firm are hopeful that our successes and the top results we are obtaining will continue well into the future.
Partner Marc Grossman
8 Drugs Doctors Would Never Take
If they won't use these medications, why should you?
July 17, 2008 | Morgan Lord, Men's Health
Filed Under: Personal Injury, Defective Drugs, Medicine
With 3,480 pages of fine print, the Physicians' Desk Reference (a.k.a. PDR) is not a quick read. That's because it contains every iota of information on more than 4,000 prescription medications. Heck, the PDR is medication — a humongous sleeping pill. Read More..
FDA Requests Boxed Warnings on Fluoroquinolone Antimicrobial Drugs
Seeks to Strengthen Warnings Concerning Increased Risk of Tendinitis and Tendon Rupture
July 8, 2008 | FDA
Filed Under: Defective Drugs, FDA Warning, FDA News
The U.S. Food and Drug Administration (FDA) has notified manufacturers of fluoroquinolone antimicrobial drugs that a Boxed Warning in the product labeling concerning the increased risk of tendinitis and tendon rupture is necessary. Through its new authority under the Food and Drug Administration Amendments Act of 2007 (FDAAA), the agency also determined that it is necessary for manufacturers of the drugs to provide a Medication Guide to patients about possible side effects. Read More..
| 
